Delivery Order SPE2DR25D1202-SPE2DR26F73HF
Award Date 12/19/25
Potential Completion Date 1/13/26
Potential Value $2.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,110.72 to AmerisourceBergen Drug Corp for Rhophylac 300 mcg/2 mL syringes on November 24, 2025, with an ultimate completion date of December 16, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Rhophylac is a Rh(D) immune globulin used to prevent Rh immunization in at-risk patients, representing a...
- The Defense Logistics Agency awarded a $1,434.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for Rhophylac 300 MCG/2 ML syringes on July 22, 2025, with an ultimate completion date of August 12, 2025. This non-set-aside delivery order represents a pediatric immunoglobulin product sourced through AmerisourceBergen's extensive federal pharmaceutical supply network. The contract will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $1,147.20 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Rhophylac 300 mcg/2 mL syringes. This competitively awarded, firm fixed-price contract is scheduled for completion by October 7, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation and represents a child order under a larger contract vehicle. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,388.40 to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Rhophylac 300 mcg/2 mL syringes. This firm fixed-price, competitively awarded contract calls for delivery to be completed by December 23, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $2,294.40 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Rhophylac 300 mcg/2 mL syringes. This contract represents a firm fixed-price delivery order with an ultimate completion date of October 6, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was competitively awarded without set-aside designation, reflecting AmerisourceBergen's continued capability to fulfill federal...
- The Defense Logistics Agency awarded a delivery order valued at $2,868 to AmerisourceBergen Drug Corp for the supply of Rhophylac 300 mcg/2 mL syringes. The contract is a firm fixed-price delivery order with an ultimate completion date of October 17, 2025, and represents a competitive award with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary operations as a...
- The Defense Logistics Agency awarded a $1,434.00 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for Rhophylac 300 mcg/2 mL syringes, with an ultimate completion date of September 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,147.20 to AmerisourceBergen Drug Corp for Rhophylac 300 mcg/2 mL syringes on August 29, 2025, with an ultimate completion date of September 22, 2025. This firm fixed price, non-set-aside contract represents a straightforward pharmaceutical procurement executed through AmerisourceBergen's existing indefinite delivery vehicle with DLA. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Rhophylac 300 mcg/2 mL syringes with a ceiling value of $1,720.80 and a firm fixed price structure. The contract is not set-aside and represents a competitive award to the pharmaceutical distributor. Performance will be completed by October 10, 2025, with fulfillment occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Rhophylac 300 mcg/2 mL syringes. The contract carries a ceiling value of $1,434.00 and is scheduled for completion by September 29, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award falls under...